Catheter Precision Announces Publication Of LockeT Data In The Journal Of Cardiovascular Electrophysiology
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision, Inc. (NYSE:VTAK) announced the publication of its first LockeT study in the Journal of Cardiovascular Electrophysiology. The study demonstrates the effectiveness and safety of the LockeT device in achieving hemostasis and facilitating early ambulation without major complications. Further studies are planned for this year.
August 06, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Catheter Precision's publication of the LockeT study in a reputable journal demonstrates the device's effectiveness and safety, potentially boosting investor confidence and stock price.
The publication in a reputable journal and the positive results of the study are likely to increase investor confidence in Catheter Precision's product, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100